Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PL-5 spray vs sulfadiazine silver cream for secondary wound infection
CTR20201038Phase 2Completed
- Sponsor
- Changchun Pulike Biological Pharmaceutical
- Start
- Jun 2020
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of peceleganan in Wound infection (WI), burn wound infection, traumatic ulcer, decubitus ulcer, Infected venous leg ulcer (IVLU), sponsored by Changchun Pulike Biological Pharmaceutical. Started Jun 2020; status: completed.
02
Drugs
peceleganan
03
Conditions
Wound infection (WI)burn wound infectiontraumatic ulcerdecubitus ulcerInfected venous leg ulcer (IVLU)
Beyond the preview
Go deeper on CTR20201038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201038.